INSIGHTS ON DRUG DEVELOPMENT
-
Platform Strategy For Improving Manufacturability And Efficacy In Bispecific Antibodies
Novel bispecific antibody engineering overcomes assembly and manufacturability challenges, enabling scalable production while preserving therapeutic function, stability, purity, and product quality.
-
Solving Formulation Challenges Across Modalities
Optimize drug delivery by leveraging advanced nanoparticle engineering to dramatically increase small-molecule oral drug loading and enable ultra-high-concentration subcutaneous formulations.
-
The Rise Of Complex OSD Generics: Understanding Development Challenges
Understanding the potential pitfalls and partnering with the right experts can make all the difference in overcoming the complexities of complex generic OSD development.
-
Real-Time Growth Monitoring Of Spheroids In Round Bottom Microplates
Real-time spheroid monitoring combines brightfield and fluorescence imaging with automated analysis. Find out how this workflow enhances reproducibility and supports high-content 3D cell culture applications.
-
Why Controlled Release Is Essential For Patient-centric Drug Development10/15/2026
Controlled release design can ease daily dosing burden by moderating swings in drug exposure, though the right approach depends on API properties and what manufacturing can deliver at scale.
-
IP Considerations In Drug Development For Biotech Companies4/20/2026
Integrate a strategic intellectual property approach early in drug development to streamline research, uncover opportunities, and maximize the return on your investment.
-
The Bioprocessing Industry Has A Digital Execution Problem8/17/2026
Digital execution remains a major barrier in manufacturing. Learn how fragmented data, manual decisions, and inconsistent adoption affect the ability to bring complex therapies to patients faster.
-
Futurizing Healthcare By Localizing The Life Sciences12/12/2024
Mustapha Bittaye's journey highlights the importance of international funding in fostering local scientific talent and biopharma resilience, empowering research and manufacturing in developing countries.
-
Ask Us Anything: Erik Feldmann On Advancing Peptide Development7/24/2026
Erik Feldmann, Technical Director, on the analytical challenges of proteins, peptides, and oligonucleotides — and why he starts every method-development problem by understanding what the customer is trying to achieve.
DRUG DEVELOPMENT SOLUTIONS
-
Our formulation development and material sciences experts have over 30 years’ experience in pre-formulation and solid state characterization.
-
MaxPeak™ Premier Columns utilize MaxPeak High Performance Surfaces that are designed to increase analyte recovery, sensitivity, and reproducibility by minimizing analyte/surface interactions that can lead to sample losses.
-
Discover a new system that offers high-speed camera options and versatile customization to enhance calcium oscillation analysis and streamline workflows for efficient drug discovery.
-
Reproducibility, reliability and carryover performance that meets your workflow demands, injection to injection, batch after batch.
ExionLC 2.0 and ExionLC 2.0+ systems provide full integration, control and compatibility with SCIEX mass spectrometers bringing together the speed and precision you expect for a complete solution that meets every challenge your lab faces.
-
Learn how to select the right media resins for your application based on various parameters such as particle size, molecular weight, fractionation ranges and pH.